Advisornet Financial’s Praxis Precision Medicines PRAX Stock Holding History

Advisornet Financial’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-20	Closed	-$6.44K	–	2352
2026 Q1	$6.44K	Buy	+20	New	+$6.19K	﹤0.01%	1669

Other funds holding PRAX

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Advisornet Financial's PRAX Position: Q2 2026 in Review

Advisornet Financial sold out of Praxis Precision Medicines (PRAX) in Q2 2026, closing a stake of 20 shares — an estimated $6.44K sold.

Advisornet Financial first reported a position in PRAX in Q1 2026 and held it in 1 quarter. The position peaked at $6.44K in Q1 2026. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

Advisornet Financial reported no remaining Praxis Precision Medicines position as of Q2 2026 after selling out during the quarter.
Advisornet Financial sold 20 Praxis Precision Medicines shares in Q2 2026, an estimated $6.44K.
Advisornet Financial first reported a position in Praxis Precision Medicines in Q1 2026 and held it in 1 quarter.
Advisornet Financial's Praxis Precision Medicines position peaked at $6.44K in Q1 2026.
309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Advisornet Financial's 13F filing for Q2 2026, filed 23 Jul 2026.